TAKE ACTION BEFORE DECEMBER 11
Contact Congress to protect federal research
Current government funding and the temporary block on OMB’s proposed grant rule expire December 11. Without congressional action, the government could face a shutdown and OMB could move forward with the rule.
Why it matters
The proposed rule could weaken independent expert review and make it easier to end grants, even when research is on track. It could disrupt ongoing studies and make it harder to share discoveries.
Urge your members of Congress to keep the government funded, complete FY2027 appropriations with strong support for research, and keep the OMB rule blocked in any funding measure.
Annual Conference
Education
Membership
About USASP
Updated November 2026
The current government funding measure and its temporary block on OMB’s proposed grant rule expires on December 11. Congress must act to keep the government funded and maintain the block on the proposed rule.
Please contact your members of Congress. Urge them to prevent a government shutdown, complete FY2027 appropriations with strong support for research, and keep the OMB rule blocked in any funding measure.
Use Research!America’s editable action alert
You can also write or call your representatives directly. A few sentences in your own words can help policymakers understand how federal research policy affects people, careers, and communities.
Why This Matters
The Office of Management and Budget (OMB) has proposed major changes to Regulation for Federal Financial Assistance (Docket No. OMB-2026-0034), the government-wide rules for federal grants and cooperative agreements.
If finalized as proposed, the rule could change how federal research grants are reviewed, managed, and ended. USASP supports proposed improvements that would make funding opportunity announcements clearer and more accessible. We are concerned that other provisions could weaken independent scientific review, make research funding less predictable, and create barriers to sharing discoveries and collaborating.
USASP’s Main Concerns
In its comment to OMB, USASP supported the proposed improvements to funding opportunity announcements (§200.204) and raised concerns about provisions that would:
· Expand political review of grant decisions and allow applicant risk assessments based on broadly defined organizational affiliations (§§200.205–200.206).
· Eliminate fixed-amount awards (§200.201).
· Treat negotiated indirect cost rates as indicators of institutional quality or stewardship (§200.333).
· Add ambiguous, non-evidence-based funding conditions (§200.300).
· Expand authority to terminate active awards (§§200.340–200.343).
· Restrict scientific dissemination, including publication and participation in scientific meetings (§§200.432, 200.454, 200.461).
· Broadly restrict legitimate international scientific collaboration (§§200.220, 200.329, 200.331, 200.332).
For pain research, these changes could affect long-term studies, clinical research, trainees, research participants, collaborations, and the timely sharing of findings that help move discoveries toward care.
What You Can Tell Your Representatives
You do not need to address every provision. Choose the issue that connects most directly to your experience, and explain why it matters to your research, career, patients, family, or community.
For example:
· How does independent scientific peer review support the quality and impact of your work?
· What could happen to your research or its participants if an active grant were ended unexpectedly?
· How do scientific meetings, publication, and collaboration help you share findings and advance pain research?
· How could less predictable research support affect trainees, early-career investigators, or the future research workforce?
· What might these changes mean for people and families waiting for better understanding, treatments, or care for pain?
USASP President Burel Goodin wrote in his public comment:
“Scientific peer review has been, and will continue to be, the gold standard for ensuring that the best scientific and technological outputs come from the United States.”
Scientific meetings and international collaboration also help researchers exchange ideas, challenge assumptions, build partnerships, mentor trainees, and accelerate discovery.
Please Take Action
Contact your senators and representative and urge them to:
· Keep the government funded and prevent a shutdown.
· Complete FY2027 appropriations with strong support for federal research and public health agencies.
· Include language in any funding measure to keep OMB’s proposed rule blocked.
Contact Congress using Research!America’s action alert
Resources
· Read USASP’s signed comment to OMB
· Read the full proposed rule in the Federal Register
· Visit Research!America’s OMB rule resource page
· Watch USASP leadership video clips about the proposed rule

